linsidomine has been researched along with 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bucher, B; Butt, E; Genieser, HG; Huggins, JP; Pöhler, D | 1 |
1 other study(ies) available for linsidomine and 8-bromo-beta-phenyl-1,n(2)-ethenoguanosine 3',5'-cyclic monophosphorothioate
Article | Year |
---|---|
Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS.
Topics: Animals; Base Sequence; Blood Platelets; Cattle; Cell Adhesion Molecules; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Humans; In Vitro Techniques; Microfilament Proteins; Molecular Sequence Data; Molsidomine; Muscle, Smooth, Vascular; Norepinephrine; Phosphoproteins; Phosphorylation; Rats; Stereoisomerism; Thionucleotides; Vasoconstriction; Vasodilator Agents | 1995 |